ConductScience.org, home

Paper508579

Cell-cycle inhibition by misonidazole of human cells cultivated in vitro under aerobic conditions.

Lindmo T and 2 others. Br J Cancer, 1979. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Cell-cycle inhibition by misonidazole of human cells cultivated in vitro under aerobic conditions. Papers, record 508579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/508579

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell-cycle inhibition by misonidazole of human cells cultivated in vitro under aerobic conditions.
PubMed
Journal
Br J Cancer
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2019-05-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lindmo TT
2Pettersen EOE O
3Wibe EE

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell CycleMajor topic
MisonidazoleMajor topic
NitroimidazolesMajor topic
Aerobiosis
Cell Line
Cell Survival
DNA
Humans
Interphase
Mitosis

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
2209810Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.Br J Cancer Suppl1978https://conductscience.org/library/papers/209810PubMed
3140713Flow cytometric measurement of the polarization of fluorescence from intracellular fluorescein in mammalian cells.Biophys J1977https://conductscience.org/library/papers/140713PubMed
4209811The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials.Br J Cancer Suppl1978https://conductscience.org/library/papers/209811PubMed
5369700Delay of cell cycle progression after X-irradiation of synchronized populations of human cells (NHIK 3025) in culture.Cell Tissue Kinet1979https://conductscience.org/library/papers/369700PubMed
6336208Cell cycle characteristics of synchronized and asynchronous populations of human cells and effect of cooling of selected mitotic cells.Cell Tissue Kinet1977https://conductscience.org/library/papers/336208PubMed
7708572Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.Br J Cancer1978https://conductscience.org/library/papers/708572PubMed
8687510Split dose cytotoxic experiments with misonidazole.Br J Cancer1978https://conductscience.org/library/papers/687510PubMed
9679180Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells.Cancer Res1978https://conductscience.org/library/papers/679180PubMed
10626969Cytological effects of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol (misonidazole) on hypoxic mammalian cells in vitro.Cancer Res1978https://conductscience.org/library/papers/626969PubMed
11861146Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.Br J Cancer1977https://conductscience.org/library/papers/861146PubMed
12856238Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.Br J Cancer1977https://conductscience.org/library/papers/856238PubMed
134133816Cell-cycle analysis in 20 minutes.Science1974https://conductscience.org/library/papers/4133816PubMed
144867897Cyclic x-ray responses in mammalian cells in vitro.Radiat Res1968https://conductscience.org/library/papers/4867897PubMed
15776494Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.Clin Radiol1976https://conductscience.org/library/papers/776494PubMed
16959489Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells.Radiat Res1976https://conductscience.org/library/papers/959489PubMed
171197663Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.Radiat Res1975https://conductscience.org/library/papers/1197663PubMed
181178881Hypoxic sensitizers: radiobiological studies at the cellular level.Radiology1975https://conductscience.org/library/papers/1178881PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
7073947Growth delay in small EMT6 spheroids induced by cytotoxic drugs and its modification by misonidazole pretreatment under hypoxic conditions.Br J Cancer1982https://conductscience.org/library/papers/7073947PubMed
7013776Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S.Br J Cancer1981https://conductscience.org/library/papers/7013776PubMed
6652020Inhibition of cell-cycle progression by acute treatment with various degrees of hypoxia: modifications induced by low concentrations of misonidazole present during hypoxia.Br J Cancer1983https://conductscience.org/library/papers/6652020PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/508579

GET https://conductscience.org/api/papers/v1/508579/authors